Through our strong mentoring plan, excellent facility development, and outstanding external advisory panel review, we have achieved remarkable success during the Phase I funding of the only bioengineering COBRE in the nation. Begun with only four projects, our program has expanded to support and mentor 13 junior faculty who have collectively received >$10M in external funding, and published 151 journal articles. Five have also received independent status. Through this COBRE funding, we have recruited three junior and two senior BioE faculty. Clemson has provided cost-share support for pilot projects and a significant expansion of core facilities, most notably a new bioengineering innovation campus (CUBEInC, $16M) with the Greenville Hospital System. CUBEInC, with 29,000 sq. ft. of laboratory and networking space for investigators and clinicians, a surgical skills facility, and a conference center, will serve as the new site for our Phase II COBRE initiative. A new bioengineering building was also opened on the MUSC campus in Charleston in 2012. This new $60M facility represents the growing statewide emphasis on bioengineering and regenerative medicine and houses the labs of five full time Clemson tenure track faculty, one of whom is the target PI in this renewal application. Through Phase I COBRE funding, the Clemson Light Imaging Facility (CLIF) is now in the new Life Sciences building on the Clemson campus under the direction of Dr. Terri Bruce, our core director. We will build on these successes in Phase II. We will expand upon biomaterials-based approach in our tissue engineering studies to a more fundamental analysis of tissue regeneration and formation through our South Carolina Bioengineering Center of Regeneration and Formation of Tissues (SC BioCRAFT). We have selected five new outstanding investigators (3 hired during COBRE Phase I) and provided startup funds to develop their research in Phase II. We have also consolidated and added new areas of core expertise. We propose a unique Bioengineering and Bioimaging (B5) Core and Cell, Tissue, and Molecular Analysis (CTMA) core facilities to support junior faculty in the state. This proposal describes our plan to build an effective scientific collaboration to sustain the SC BioCRAFT beyond P20 funding while strengthening the bioengineering and tissue regeneration scientific community in our state and nationally.
Our specific aims are to 1) expand the critical mass of funded investigators affiliated with the COBRE through mentoring in research career development of five additional outstanding targeted investigators with interests and talents relevant to our theme;2) enhance our core to help our targeted faculty compete successfully for NIH funding and forge collaborations with investigators statewide, including COBRE graduates and non-COBRE researchers with relevant interests and;3) Promote formal recognition of SC BioCRAFT as a designated, sustainable University recognized research center to support the transition from COBRE to long-term competitive support from diverse federal and non-federal sources.

Public Health Relevance

The overarching theme of the Bioengineering Center of Regeneration and Formation of Tissues (SC BioCRAFT) is tissue regeneration, which is highly relevant to NIH's mission of applying fundamental knowledge about the nature and behavior of living systems to enhance health, lengthen life, and reduce illness and disability. As the nation's only bioengineering COBRE center, we are currently supporting projects and cores to find novel methods to restore or regenerate diseased neural, cardiovascular, and bone tissues.

Agency
National Institute of Health (NIH)
Type
Exploratory Grants (P20)
Project #
2P20GM103444-06
Application #
8742729
Study Section
Special Emphasis Panel (ZGM1)
Program Officer
Canto, Maria Teresa
Project Start
Project End
Budget Start
Budget End
Support Year
6
Fiscal Year
2014
Total Cost
Indirect Cost
Name
Clemson University
Department
Biomedical Engineering
Type
Biomed Engr/Col Engr/Engr Sta
DUNS #
City
Clemson
State
SC
Country
United States
Zip Code
29634
Yang, Huaxiao; Schmidt, Lucas P; Wang, Zhonghai et al. (2016) Dynamic Myofibrillar Remodeling in Live Cardiomyocytes under Static Stretch. Sci Rep 6:20674
Barnes, Ralston M; Harris, Ian S; Jaehnig, Eric J et al. (2016) MEF2C regulates outflow tract alignment and transcriptional control of Tdgf1. Development 143:774-9
Jia, Jia; Coyle, Robert C; Richards, Dylan J et al. (2016) Development of peptide-functionalized synthetic hydrogel microarrays for stem cell and tissue engineering applications. Acta Biomater 45:110-120
Huang, Ting; Wang, Zhonghai; Wei, Lina et al. (2016) Microelectrode Array-evaluation of Neurotoxic Effects of Magnesium as an Implantable Biomaterial. J Mater Sci Technol 32:89-96
Uchida, Noriyuki; Sivaraman, Srikanth; Amoroso, Nicholas J et al. (2016) Nanometer-sized extracellular matrix coating on polymer-based scaffold for tissue engineering applications. J Biomed Mater Res A 104:94-103
Lehnert, Matthew S; Beard, Charles E; Gerard, Patrick D et al. (2016) Structure of the lepidopteran proboscis in relation to feeding guild. J Morphol 277:167-82
Nosoudi, Nasim; Chowdhury, Aniqa; Siclari, Steven et al. (2016) Reversal of Vascular Calcification and Aneurysms in a Rat Model Using Dual Targeted Therapy with EDTA- and PGG-Loaded Nanoparticles. Theranostics 6:1975-1987
Coyle, Robert; Jia, Jia; Mei, Ying (2016) Polymer microarray technology for stem cell engineering. Acta Biomater 34:60-72
Richards, Dylan; Jia, Jia; Yost, Michael et al. (2016) 3D Bioprinting for Vascularized Tissue Fabrication. Ann Biomed Eng :
Parasaram, Vaideesh; Nosoudi, Nasim; LeClair, Renee J et al. (2016) Targeted drug delivery to emphysematous lungs: Inhibition of MMPs by doxycycline loaded nanoparticles. Pulm Pharmacol Ther 39:64-73

Showing the most recent 10 out of 91 publications